|
|
|
Volumn 45, Issue 1, 2004, Pages 111-112
|
|
Tragic consequences of inadequate health technology assessment.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTIFICIAL MILK;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
BRAIN DISEASE;
CHEMISTRY;
DRUG APPROVAL;
EDITORIAL;
HEALTH CARE POLICY;
HUMAN;
INFANT;
ISRAEL;
METHODOLOGY;
NEWBORN;
PATHOPHYSIOLOGY;
SAFETY;
SOYBEAN MILK;
STANDARD;
THIAMINE DEFICIENCY;
BRAIN DISEASES;
CONSUMER PRODUCT SAFETY;
DRUG APPROVAL;
HEALTH POLICY;
HUMANS;
INFANT;
INFANT FORMULA;
INFANT, NEWBORN;
ISRAEL;
SOY MILK;
TECHNOLOGY ASSESSMENT, BIOMEDICAL;
THIAMINE DEFICIENCY;
|
|
EID: 2342516761
PISSN: 03539504
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
